insights_auto
Why is SBS up २.४०%?
Dive Deeperchevron_right
SBS:ETR
Stratec SE
€ २३.४५
arrow_upward
+२.४०%(+०.५५) 1D
अक्टोबर १२, १७:३५:१७ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
€ २३.००
High
€ २३.४५
Low
€ २३.००
Mkt. cap
२८.६८ करोड
Avg. vol.
१३.७४ हजार
Volume
१३.२२ हजार
Dividend
२.५६%
Quarterly dividend
€ ०.१५
Ex-dividend date
२०२६ जुन २४
52-wk high
€ ३०.५०
52-wk low
€ १६.३०
EPS
-€ ०.०३
Shares outstanding
१.२२ करोड
No. of employees
१ हजार
Open
€ २३.००
High
€ २३.४५
Low
€ २३.००
Mkt. cap
२८.६८ करोड
Avg. vol.
१३.७४ हजार
Volume
१३.२२ हजार
Dividend
२.५६%
Quarterly dividend
€ ०.१५
Ex-dividend date
२०२६ जुन २४
52-wk high
€ ३०.५०
52-wk low
€ १६.३०
EPS
-€ ०.०३
Shares outstanding
१.२२ करोड
No. of employees
१ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
१ घण्टा पहिले
mwb research downgraded Stratec stock to Sell at EUR 21.00 target
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE